Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
60.69
-0.91 (-1.48%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Cytokinetics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 7,540 | 7,769 | 5,551 | 8,186 | 4,336 | 3,823 | |
| Market Cap Growth | 64.75% | 39.94% | -32.19% | 88.80% | 13.41% | 159.96% | |
| Enterprise Value | 8,097 | 8,156 | 5,448 | 8,396 | 4,210 | 3,612 | |
| Last Close Price | 60.69 | 63.54 | 47.04 | 83.49 | 45.82 | 45.58 | |
| PS Ratio | 85.64 | 88.24 | 300.50 | 1087.18 | 45.84 | 54.29 | |
| PB Ratio | - | -11.78 | -41.01 | -21.19 | -40.18 | 15.68 | |
| P/TBV Ratio | - | - | - | - | - | 15.68 | |
| EV/Sales Ratio | 91.97 | 92.65 | 294.90 | 1115.03 | 44.50 | 51.29 | |
| Debt / Equity Ratio | -2.18 | -2.18 | -6.82 | -1.96 | -6.95 | 1.11 | |
| Net Debt / Equity Ratio | -0.84 | -0.84 | 1.13 | -0.36 | 0.30 | -0.83 | |
| Net Debt / EBITDA Ratio | -0.92 | -0.92 | 0.29 | -0.29 | 0.10 | 1.10 | |
| Net Debt / FCF Ratio | -1.04 | -1.04 | 0.38 | -0.34 | 0.10 | 1.05 | |
| Asset Turnover | 0.06 | 0.06 | 0.02 | 0.01 | 0.10 | 0.10 | |
| Quick Ratio | 4.45 | 4.45 | 6.08 | 6.00 | 9.25 | 7.35 | |
| Current Ratio | 4.53 | 4.53 | 6.17 | 6.12 | 9.40 | 7.45 | |
| Return on Equity (ROE) | - | - | - | - | -572.15% | -120.54% | |
| Return on Assets (ROA) | -27.08% | -27.08% | -30.11% | -33.73% | -21.83% | -16.94% | |
| Return on Capital Employed (ROCE) | -50.10% | -50.10% | -43.90% | -68.80% | -34.90% | -24.20% | |
| Earnings Yield | -10.41% | -10.10% | -10.62% | -6.43% | -8.97% | -5.63% | |
| FCF Yield | -7.09% | -6.88% | -7.20% | -5.08% | -7.17% | -5.01% | |
| Buyback Yield / Dilution | -7.26% | -7.26% | -16.01% | -7.46% | -16.83% | -19.16% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.